Evaluation of Weight Bearing After Total Hip and Knee Replacement
NCT ID: NCT01135160
Last Updated: 2024-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
100 participants
OBSERVATIONAL
2014-11-30
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the literature there is no data so far about the way patient take care of the recommended weight bearing during the first 6 weeks after THA and TKA.
Over a one year period starting August 2010 all patients undergoing TKA or THA at the investigators institution will have a technical device in their shoes (sole) to measure the load in each step they do in these shoes during the first 6 weeks. Patients are asked to fill out a standardised pain protocol every day (VAS) and document need of pain medication. The investigators recommend 20kg of weight on the operated leg for 6 weeks and full weight bearing at the end of week six.
The investigators believe that patients will adjust weight bearing to their level of pain and not to their surgeons recommendations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight-bearing Recommendation After Replacement of the Hip or Knee Joint
NCT00266396
Total Hip Arthroplasty and Physical Activity in Patients Younger Than 50 Years
NCT05189964
Does Rehabilitation After Total Hip and Knee Arthroplasty Work
NCT03750448
A Clinical Evaluation of Wear Couples in THA
NCT00374946
Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment
NCT04226339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TKA/THA
All patients receiving TKA/THA meeting inclusion but not exclusion criteria
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* is able to walk on crutches
* is able to understand our recommendations
* signed informed consent
Exclusion Criteria
* not able to understand our recommendations
* other deformities of lower limbs
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Münsterlingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Schueler, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Chief of the department for orthopedic surgery Kantonsspital Münsterlingen, Schweiz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Münsterlingen
Münsterlingen, Thurgau, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSM 2010-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.